Inducible (physical) urticaria — symptomatic dermographism & delayed pressure
Weals provoked by scratching or sustained pressure · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Symptomatic dermographism produces linear weals within minutes of stroking the skin, while delayed pressure urticaria causes deep painful swelling hours after sustained pressure. Both are chronic inducible urticarias managed with trigger avoidance and up-dosed antihistamines.
Red flags
- Weals lasting >24 h, painful or leaving bruising (urticarial vasculitis)
- Associated arthralgia, fever or systemic upset
- Angioedema with airway symptoms
- Flushing with syncope (consider mastocytosis)
- Failure to respond to fourfold antihistamine dosing
Assessment
Differential diagnosis
- Chronic spontaneous urticaria
- Cholinergic urticaria
- Cold or solar urticaria
- Urticarial vasculitis
- Mastocytosis / cutaneous mastocytoma
Investigations
- Provocation testing: stroke the skin (dermographism) or apply calibrated pressure (FricTest / weights)
- FBC and ESR/CRP (raised inflammatory markers suggest vasculitis)
- Thyroid function and autoantibodies if chronic
- Skin biopsy only if lesions last >24 h, are painful or bruise (exclude vasculitis)
- Baseline tryptase if flushing/systemic features
Management
- Confirm the inducible subtype with appropriate provocation testing
- Advise avoidance of friction, scratching, tight clothing and sustained pressure
- Start a non-sedating H1 antihistamine as first-line
- Up-dose the antihistamine stepwise (up to fourfold) if inadequate control
- Add an alternative or second antihistamine / H2 blocker if still symptomatic
- Reserve short corticosteroid courses for severe delayed-pressure flares only
- Refer refractory cases for omalizumab consideration
- Reassure that inducible urticarias are not allergic and usually remit over time
Drugs & doses
Cetirizine — 10 mg orally once daily, up-dosed to 40 mg/day as needed
Fexofenadine — 180 mg orally once daily, up to 360 mg/day
Montelukast — 10 mg orally at night as add-on for delayed pressure urticaria
Omalizumab — 300 mg SC every 4 weeks for antihistamine-refractory disease
Prednisolone — 20-40 mg orally daily for short courses in severe delayed pressure flares
Disposition
Manage in primary care or dermatology/allergy clinic; no admission needed unless airway angioedema coexists.
Complications & pitfalls
- Chronic sleep disturbance and impaired quality of life
- Occupational impact from pressure-provoked swelling
- Corticosteroid adverse effects with repeated courses
- Misdiagnosis as allergy leading to unnecessary avoidance
- Secondary skin infection from scratching
Exam pearls
- Dermographism is diagnosed at the bedside by stroking the skin and watching for a weal
- Delayed pressure urticaria responds poorly to antihistamines alone — montelukast or omalizumab may help
- Inducible urticarias are not IgE allergies — no food/drug avoidance is needed
- Up-dosing antihistamines fourfold is evidence-based and safe before escalating
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.